Global Specimen Solutions, Inc. Announces 5-Year Strategic Alliance with Covance

RALEIGH, NC (PRWEB) OCTOBER 13, 2016

Global Specimen Solutions (GSS) today announced a five-year strategic alliance with Covance, the drug development business of Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:LH). Covance’s market-leading central laboratory will offer GSS products GlobalCODE® and snapTRACK™ to its pharmaceutical and biotechnology clients to provide streamlined global specimen tracking, as well as informed consent and assay result management that will deliver actionable insights from specimens across development programs. Covance will be the exclusive lab to offer GSS’s services for pharmaceutical development.

Read the Full Press Release Here